You have 9 free searches left this month | for more free features.

Metastatic kidney cancer

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Biopsy
  • +8 more
  • (no location specified)
Jun 8, 2023

Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

Recruiting
  • Kidney Cancer
  • cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 2, 2022

Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)

Not yet recruiting
  • Cancer
  • +8 more
  • DK210 (EGFR)
  • +3 more
  • (no location specified)
Jan 27, 2023

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

Not yet recruiting
  • Renal Cell Carcinoma
  • +2 more
  • Implantable Microdevice (IMD)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 17, 2023

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

Recruiting
  • Kidney Cancer
  • +2 more
  • Cytoreductive nephrectomy±metastasectomy
  • Human-derived materials sampling
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Mar 2, 2023

Describe Kidney Cancer Patient Population Treatment, and Results

Not yet recruiting
  • Renal Cell Cancer
  • +6 more
    • (no location specified)
    May 2, 2022

    Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial (Computed Tomography, Magnetic Resonance Imaging,

    Not yet recruiting
    • Metastatic Renal Cell Carcinoma
    • Stage IV Renal Cell Cancer AJCC v8
    • Computed Tomography
    • +4 more
    • (no location specified)
    May 8, 2023

    Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Chicago (Stereotactic Body

    Recruiting
    • Metastatic Renal Cell Cancer
    • +2 more
    • Stereotactic Body Radiation Therapy
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Jun 3, 2022

    Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

    Recruiting
    • Urothelial Cancer
    • +3 more
    • Sacituzumab Govitecan (SG)
    • Enfortumab vedotin-ejfv (EV)
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 28, 2022

    BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer)

    Recruiting
    • Renal Cancer Metastatic
    • Immunological and tumour characterization
    • Lyon, France
      Centre Leon Berard
    Mar 14, 2022

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Baltimore, Maryland
      Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
    Mar 14, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder

    Active, not recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +35 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
    • +7 more
    Jan 3, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

    Active, not recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +20 more
    • Ipilimumab
    • +3 more
    • Tampa, Florida
    • +6 more
    Jan 13, 2023

    Kidney Cancer Trial in Birmingham (Acarbose Tablets)

    Not yet recruiting
    • Kidney Cancer
    • Acarbose Tablets
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 2, 2022

    Metastatic Melanoma, Lung Cancer, Renal Cancer, Squamous Cell

    Withdrawn
    • Multiple Indications Cancer
    • Non-Interventional
    • Mexico, Distrito Federal, Mexico
      Local Institution
    May 25, 2022

    Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

    Recruiting
    • Renal Cancer
    • +2 more
      • Amsterdam, Noord Holland, Netherlands
        Amsterdam UMC locatie VUMC
      Jan 20, 2023

      Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,

      Recruiting
      • Malignant Digestive System Neoplasm
      • +12 more
      • Computed Tomography
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 22, 2022

      Hyper-Personalized Medicine Using Patient Derived Xenografts for

      Recruiting
      • Kidney Neoplasm
      • +2 more
        • Toronto, Ontario, Canada
          Odette Cancer Centre
        Mar 24, 2022

        Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed

        Recruiting
        • Anatomic Stage IV Breast Cancer AJCC v8
        • +19 more
        • Computed Tomography
        • +3 more
        • Los Angeles, California
          USC / Norris Comprehensive Cancer Center
        Aug 19, 2022

        Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

        Recruiting
        • Solid Tumor, Adult
        • +19 more
        • Irving, Texas
        • +2 more
        May 24, 2023

        Kidney Cancer Trial in New Brunswick (therapeutic allogeneic lymphocytes, sunitinib malate)

        Terminated
        • Kidney Cancer
        • therapeutic allogeneic lymphocytes
        • sunitinib malate
        • New Brunswick, New Jersey
          Rutgers Cancer Institute of New Jersey
        Apr 23, 2021

        Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Los Angeles

        Completed
        • Clear Cell Renal Cell Carcinoma
        • +2 more
        • AdGMCAIX-transduced autologous dendritic cells
        • +2 more
        • Los Angeles, California
          Jonsson Comprehensive Cancer Center
        Jul 28, 2021